Mediators of oligodendrocyte differentiation during remyelination

FEBS Letters

Volumn 585, Issue 23, 2011, Pages 3730-3737

  Patel, Jigisha R ^a   Klein, Robyn S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Cytokines; Growth factor; MicroRNA; Multiple sclerosis; Transcription factor

Indexed keywords

BIIB 033; CENTRAL NERVOUS SYSTEM AGENTS; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; MICRORNA; MYELIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR OLIG1; TRANSCRIPTION FACTOR SOX10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; CELL SURVIVAL; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE EXACERBATION; DRUG TREATMENT FAILURE; EXTRACELLULAR MATRIX; HUMAN; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CHEMOKINES; HUMANS; MICRORNAS; MYELIN SHEATH; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 81755179427     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.04.037     Document Type: Review

References (111)

1. K.A. Irvine, and W.F. Blakemore Remyelination protects axons from demyelination-associated axon degeneration Brain 131 2008 1464 1477 (Pubitemid 351806463)
2. R.J. Franklin Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3 2002 705 714 (Pubitemid 135706676)
3. N. De Stefano, P.M. Matthews, L. Fu, S. Narayanan, J. Stanley, G.S. Francis, J.P. Antel, and D.L. Arnold Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study Brain 121 Pt 8 1998 1469 1477 (Pubitemid 28349900)
4. G.K. Matsushima, and P. Morell The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system Brain Pathol. 11 2001 107 116
5. A. Aguirre, J.L. Dupree, J.M. Mangin, and V. Gallo A functional role for EGFR signaling in myelination and remyelination Nat. Neurosci. 10 2007 990 1002 (Pubitemid 47185206)
6. N. Baumann, and D. Pham-Dinh Biology of oligodendrocyte and myelin in the mammalian central nervous system Physiol. Rev. 81 2001 871 927 (Pubitemid 32267079)
7. J.M. Levine, R. Reynolds, and J.W. Fawcett The oligodendrocyte precursor cell in health and disease Trends Neurosci. 24 2001 39 47 (Pubitemid 32332895)
8. B. Menn, J.M. Garcia-Verdugo, C. Yaschine, O. Gonzalez-Perez, D. Rowitch, and A. Alvarez-Buylla Origin of oligodendrocytes in the subventricular zone of the adult brain J. Neurosci. 26 2006 7907 7918 (Pubitemid 44315160)
9. J.R. Patel, E.E. McCandless, D. Dorsey, and R.S. Klein CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination Proc. Natl. Acad. Sci. USA 107 2010 11062 11067
10. B. Nait-Oumesmar, N. Picard-Riera, C. Kerninon, and A. Baron-Van Evercooren The role of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis J. Neurol. Sci. 265 2008 26 31
11. K.S. Carbajal, C. Schaumburg, R. Strieter, J. Kane, and T.E. Lane Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis Proc. Natl. Acad. Sci. USA 107 2010 11068 11073
12. A. Aguirre, and V. Gallo Reduced EGFR signaling in progenitor cells of the adult subventricular zone attenuates oligodendrogenesis after demyelination Neuron Glia Biol. 3 2007 209 220 (Pubitemid 351594229)
13. B. Nait-Oumesmar, L. Decker, F. Lachapelle, V. Avellana-Adalid, C. Bachelin, and A.B. Van Evercooren Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination Eur. J. Neurosci. 11 1999 4357 4366 (Pubitemid 30009267)
14. M. Lindner, S. Heine, K. Haastert, N. Garde, J. Fokuhl, F. Linsmeier, C. Grothe, W. Baumgartner, and M. Stangel Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination Neuropathol. Appl. Neurobiol. 34 2008 105 114
15. H.A. Arnett, J. Mason, M. Marino, K. Suzuki, G.K. Matsushima, and J.P. Ting TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination Nat. Neurosci. 4 2001 1116 1122 (Pubitemid 34116557)
16. J.L. Mason, K. Suzuki, D.D. Chaplin, and G.K. Matsushima Interleukin-1beta promotes repair of the CNS J. Neurosci. 21 2001 7046 7052
17. M.P. Hosking, E. Tirotta, R.M. Ransohoff, and T.E. Lane CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination PLoS One 5 2010 e11340
18. L. Liu, A. Belkadi, L. Darnall, T. Hu, C. Drescher, A.C. Cotleur, D. Padovani-Claudio, T. He, K. Choi, T.E. Lane, R.H. Miller, and R.M. Ransohoff CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis Nat. Neurosci. 13 2010 319 326
19. L. Liu, L. Darnall, T. Hu, K. Choi, T.E. Lane, and R.M. Ransohoff Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells J. Neurosci. 30 2010 9074 9083
20. K.M. Omari, G. John, R. Lango, and C.S. Raine Role for CXCR2 and CXCL1 on glia in multiple sclerosis Glia 53 2006 24 31 (Pubitemid 43076209)
21. A. Aguirre, M.E. Rubio, and V. Gallo Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal Nature 467 2010 323 327
22. J. Nakahara, K. Kanekura, M. Nawa, S. Aiso, and N. Suzuki Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis J. Clin. Invest. 119 2009 169 181
23. G.R. John, S.L. Shankar, B. Shafit-Zagardo, A. Massimi, S.C. Lee, C.S. Raine, and C.F. Brosnan Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation Nat. Med. 8 2002 1115 1121 (Pubitemid 35175966)
24. C.F. Brosnan, K. Selmaj, and C.S. Raine Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis J. Neuroimmunol. 18 1988 87 94 (Pubitemid 18075674)
25. J.C. Murtie, Y.X. Zhou, T.Q. Le, A.C. Vana, and R.C. Armstrong PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination Neurobiol. Dis. 19 2005 171 182 (Pubitemid 40544734)
26. M. Kitada, and D.H. Rowitch Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord Glia 54 2006 35 46 (Pubitemid 43980032)
27. K.L. Ligon, S.P. Fancy, R.J. Franklin, and D.H. Rowitch Olig gene function in CNS development and disease Glia 54 2006 1 10 (Pubitemid 43980029)
28. Y. Qi, J. Cai, Y. Wu, R. Wu, J. Lee, H. Fu, M. Rao, L. Sussel, J. Rubenstein, and M. Qiu Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor Development 128 2001 2723 2733 (Pubitemid 32701001)
29. A. Junker, M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, R. Bittner, H. Lassmann, H. Wekerle, R. Hohlfeld, and E. Meinl MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 Brain 132 2009 3342 3352
30. K.A. Nave Oligodendrocytes and the "micro brake" of progenitor cell proliferation Neuron 65 2010 577 579
31. X. Zhao, X. He, X. Han, Y. Yu, F. Ye, Y. Chen, T. Hoang, X. Xu, Q.S. Mi, M. Xin, F. Wang, B. Appel, and Q.R. Lu MicroRNA-mediated control of oligodendrocyte differentiation Neuron 65 2010 612 626
32. J.C. Dugas, T.L. Cuellar, A. Scholze, B. Ason, A. Ibrahim, B. Emery, J.L. Zamanian, L.C. Foo, M.T. McManus, and B.A. Barres Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination Neuron 65 2010 597 611
33. J.L. Banyer, N.H. Hamilton, I.A. Ramshaw, and A.J. Ramsay Cytokines in innate and adaptive immunity Rev. Immunogenet. 2 2000 359 373 (Pubitemid 32041162)
34. J. Jin, Y. Chang, and W. Wei Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis Acta Pharmacol. Sin. 31 2010 1133 1140
35. L.H. Kircik, and J.Q. Del Rosso Anti-TNF agents for the treatment of psoriasis J. Drugs Dermatol. 8 2009 546 559
36. S. Nikolaus, and S. Schreiber Anti-TNF biologics in the treatment of chronic inflammatory bowel disease Internist. (Berl.) 49 2008 947 948 950-953
37. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190 (Pubitemid 36936912)
38. B.C. Barnhart, and M.E. Peter The TNF receptor 1: A split personality complex Cell 114 2003 148 150 (Pubitemid 36936906)
39. J. Beck, P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, and J. Wietzerbin Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78 1988 318 323 (Pubitemid 18266650)
40. D. Maimone, S. Gregory, B.G. Arnason, and A.T. ReDer Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis J. Neuroimmunol. 32 1991 67 74
41. M.K. Sharief, and R. Hentges Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis N. Engl. J. Med. 325 1991 467 472
42. M.A. Gimenez, J. Sim, A.S. Archambault, R.S. Klein, and J.H. Russell A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord Am. J. Pathol. 168 2006 1200 1209
43. L. Probert, D. Plows, G. Kontogeorgos, and G. Kollias The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice Eur. J. Immunol. 25 1995 1794 1797
44. N.H. Ruddle, C.M. Bergman, K.M. McGrath, E.G. Lingenheld, M.L. Grunnet, S.J. Padula, and R.B. Clark An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis J. Exp. Med. 172 1990 1193 1200 (Pubitemid 20343220)
45. K. Selmaj, W. Papierz, A. Glabinski, and T. Kohno Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I J. Neuroimmunol. 56 1995 135 141
46. K. Selmaj, C.S. Raine, and A.H. Cross Anti-tumor necrosis factor therapy abrogates autoimmune demyelination Ann. Neurol. 30 1991 694 700
47. K.W. Selmaj, and C.S. Raine Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors Neurology 45 1995 S44 49
48. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457-465.
49. B.A. de Jong, T.W. Huizinga, E.L. Bollen, B.M. Uitdehaag, G.P. Bosma, M.A. Van Buchem, E.J. Remarque, A.C. Burgmans, N.F. Kalkers, C.H. Polman, and R.G. Westendorp Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis J. Neuroimmunol. 126 2002 172 179 (Pubitemid 34521742)
50. S. Takikita, T. Takano, T. Narita, M. Takikita, M. Ohno, and M. Shimada Neuronal apoptosis mediated by IL-1 beta expression in viral encephalitis caused by a neuroadapted strain of the mumps virus (Kilham Strain) in hamsters Exp. Neurol. 172 2001 47 59 (Pubitemid 33141153)
51. J.E. Merrill Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro Dev. Neurosci. 13 1991 130 137
52. A. Brogi, M. Strazza, M. Melli, and E. Costantino-Ceccarini Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes J. Cell Biochem. 66 1997 532 541 (Pubitemid 27377618)
53. J.L. Mason, S. Xuan, I. Dragatsis, A. Efstratiadis, and J.E. Goldman Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination J. Neurosci. 23 2003 7710 7718 (Pubitemid 37034089)
54. S.S. Shaftel, T.J. Carlson, J.A. Olschowka, S. Kyrkanides, S.B. Matousek, and M.K. O'Banion Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration J. Neurosci. 27 2007 9301 9309 (Pubitemid 47358197)
55. R. Stumm, A. Kolodziej, S. Schulz, J.D. Kohtz, and V. Hollt Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon J. Comp. Neurol. 502 2007 382 399 (Pubitemid 46559485)
56. R. Stumm, and V. Hollt CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain J. Mol. Endocrinol. 38 2007 377 382 (Pubitemid 46723253)
57. H.H. Tsai, E. Frost, V. To, S. Robinson, C. Ffrench-Constant, R. Geertman, R.M. Ransohoff, and R.H. Miller The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration Cell 110 2002 373 383
58. T. Nagasawa A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis Int. J. Hematol. 72 2000 408 411
59. M. Doitsidou, M. Reichman-Fried, J. Stebler, M. Koprunner, J. Dorries, D. Meyer, C.V. Esguerra, T. Leung, and E. Raz Guidance of primordial germ cell migration by the chemokine SDF-1 Cell 111 2002 647 659 (Pubitemid 35441247)
60. G. Valentin, P. Haas, and D. Gilmour The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b Curr. Biol. 17 2007 1026 1031 (Pubitemid 46899533)
61. P. Gottle, D. Kremer, S. Jander, V. Odemis, J. Engele, H.P. Hartung, and P. Kury Activation of CXCR7 receptor promotes oligodendroglial cell maturation Ann. Neurol. 68 2010 915 924
62. M. Dziembowska, T.N. Tham, P. Lau, S. Vitry, F. Lazarini, and M. Dubois-Dalcq A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors Glia 50 2005 258 269 (Pubitemid 40769855)
63. S. Maysami, D. Nguyen, F. Zobel, C. Pitz, S. Heine, M. Hopfner, and M. Stangel Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12 Neuroreport 17 2006 1187 1190 (Pubitemid 44051410)
64. T.M. Calderon, E.A. Eugenin, L. Lopez, S.S. Kumar, J. Hesselgesser, C.S. Raine, and J.W. Berman A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein J. Neuroimmunol. 177 2006 27 39 (Pubitemid 44108231)
65. W.D. Hill, D.C. Hess, A. Martin-Studdard, J.J. Carothers, J. Zheng, D. Hale, M. Maeda, S.C. Fagan, J.E. Carroll, and S.J. Conway SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury J. Neuropathol. Exp. Neurol. 63 2004 84 96 (Pubitemid 38030236)
66. E.E. McCandless, L. Piccio, B.M. Woerner, R.E. Schmidt, J.B. Rubin, A.H. Cross, and R.S. Klein Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis Am. J. Pathol. 172 2008 799 808 (Pubitemid 351354551)
67. K. Zhang, G.A. McQuibban, C. Silva, G.S. Butler, J.B. Johnston, J. Holden, I. Clark-Lewis, C.M. Overall, and C. Power HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration Nat. Neurosci. 6 2003 1064 1071 (Pubitemid 37186198)
68. E.E. McCandless, Q. Wang, B.M. Woerner, J.M. Harper, and R.S. Klein CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis J. Immunol. 177 2006 8053 8064 (Pubitemid 44846323)
69. E.E. McCandless, M. Budde, J.R. Lees, D. Dorsey, E. Lyng, and R.S. Klein IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis J. Immunol. 183 2009 613 620
70. Y. Han, T. He, D.R. Huang, C.A. Pardo, and R.M. Ransohoff TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes J. Clin. Invest. 108 2001 425 435 (Pubitemid 32730789)
71. L. Cruz-Orengo, D.W. Holman, D. Dorsey, L. Zhou, P. Zhang, M. Wright, E.E. McCandless, J.R. Patel, G.D. Luker, D.R. Littman, J.H. Russell, and R.S. Klein CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity J. Exp. Med. 208 2011 327 339
72. I.F. Charo, and R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N. Engl. J. Med. 354 2006 610 621 (Pubitemid 43209108)
73. K.M. Omari, G.R. John, S.C. Sealfon, and C.S. Raine CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis Brain 128 2005 1003 1015 (Pubitemid 40675456)
74. R. Filipovic, I. Jakovcevski, and N. Zecevic GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions Dev. Neurosci. 25 2003 279 290 (Pubitemid 37100220)
75. K.M. Omari, S.E. Lutz, L. Santambrogio, S.A. Lira, and C.S. Raine Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1 Am. J. Pathol. 174 2009 164 176
76. M. Pevsner-Fischer, V. Morad, M. Cohen-Sfady, L. Rousso-Noori, A. Zanin-Zhorov, S. Cohen, I.R. Cohen, and D. Zipori Toll-like receptors and their ligands control mesenchymal stem cell functions Blood 109 2007 1422 1432 (Pubitemid 46239573)
77. A. Rolls, R. Shechter, A. London, Y. Ziv, A. Ronen, R. Levy, and M. Schwartz Toll-like receptors modulate adult hippocampal neurogenesis Nat. Cell Biol. 9 2007 1081 1088 (Pubitemid 47338146)
78. S.A. Back, T.M. Tuohy, H. Chen, N. Wallingford, A. Craig, J. Struve, N.L. Luo, F. Banine, Y. Liu, A. Chang, B.D. Trapp, B.F. Bebo Jr.; M.S. Rao, and L.S. Sherman Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation Nat. Med. 11 2005 966 972 (Pubitemid 41294442)
79. J.A. Sloane, C. Batt, Y. Ma, Z.M. Harris, B. Trapp, and T. Vartanian Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 Proc. Natl. Acad. Sci. USA 107 2010 11555 11560
80. G. Scalabrino, D. Galimberti, E. Mutti, D. Scalabrini, D. Veber, M. De Riz, F. Bamonti, E. Capello, G.L. Mancardi, and E. Scarpini Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis Brain Res. 1333 2010 64 71
81. E.E. Frost, J.A. Nielsen, T.Q. Le, and R.C. Armstrong PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination J. Neurobiol. 54 2003 457 472 (Pubitemid 36152571)
82. J.L. Mason, J.J. Jones, M. Taniike, P. Morell, K. Suzuki, and G.K. Matsushima Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination J. Neurosci. Res. 61 2000 251 262 (Pubitemid 30620056)
83. J.L. Mason, P. Ye, K. Suzuki, A.J. D'Ercole, and G.K. Matsushima Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination J. Neurosci. 20 2000 5703 5708 (Pubitemid 30636897)
84. J.A. Frank, N. Richert, B. Lewis, C. Bash, T. Howard, R. Civil, R. Stone, J. Eaton, H. McFarland, and T. Leist A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients Multi Scler. 8 2002 24 29 (Pubitemid 34193024)
85. B. Emery Regulation of oligodendrocyte differentiation and myelination Science 330 2010 779 782
86. S.P. Fancy, M.R. Kotter, E.P. Harrington, J.K. Huang, C. Zhao, D.H. Rowitch, and R.J. Franklin Overcoming remyelination failure in multiple sclerosis and other myelin disorders Exp. Neurol. 225 2010 18 23
87. S. Mi, X. Lee, Z. Shao, G. Thill, B. Ji, J. Relton, M. Levesque, N. Allaire, S. Perrin, B. Sands, T. Crowell, R.L. Cate, J.M. McCoy, and R.B. Pepinsky LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex Nat Neurosci. 7 2004 221 228 (Pubitemid 38280445)
88. S. Mi, R.H. Miller, W. Tang, X. Lee, B. Hu, W. Wu, Y. Zhang, C.B. Shields, S. Miklasz, D. Shea, J. Mason, R.J. Franklin, B. Ji, Z. Shao, A. Chedotal, F. Bernard, A. Roulois, J. Xu, V. Jung, and B. Pepinsky Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells Ann. Neurol. 65 2009 304 315
89. S. Mi, B. Hu, K. Hahm, Y. Luo, E.S. Kam Hui, Q. Yuan, W.M. Wong, L. Wang, H. Su, T.H. Chu, J. Guo, W. Zhang, K.F. So, B. Pepinsky, Z. Shao, C. Graff, E. Garber, V. Jung, E.X. Wu, and W. Wu LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis Nat. Med. 13 2007 1228 1233 (Pubitemid 47530642)
90. BiogenIdec (2010) Safety Study of BIIB033 in Subjects with Multiple Sclerosis. http://ClinicalTrialsFeeds.org/clinical-trials/show/NCT01244139.
91. N. Gaiano, and G. Fishell The role of notch in promoting glial and neural stem cell fates Annu. Rev. Neurosci. 25 2002 471 490 (Pubitemid 34748025)
92. S. Wang, A.D. Sdrulla, G. diSibio, G. Bush, D. Nofziger, C. Hicks, G. Weinmaster, and B.A. Barres Notch receptor activation inhibits oligodendrocyte differentiation Neuron 21 1998 63 75 (Pubitemid 28355692)
93. T. Kondo, and M. Raff Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation Development 127 2000 2989 2998 (Pubitemid 30611892)
94. T. Ohtsuka, M. Ishibashi, G. Gradwohl, S. Nakanishi, F. Guillemot, and R. Kageyama Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation EMBO J. 18 1999 2196 2207 (Pubitemid 29179176)
95. C.F. Brosnan, and G.R. John Revisiting Notch in remyelination of multiple sclerosis lesions J. Clin. Invest. 119 2009 10 13
96. G. Stefani, and F.J. Slack Small non-coding RNAs in animal development Nat Rev. Mol. Cell Biol. 9 2008 219 230 (Pubitemid 351301826)
97. H.A. Arnett, S.P. Fancy, J.A. Alberta, C. Zhao, S.R. Plant, S. Kaing, C.S. Raine, D.H. Rowitch, R.J. Franklin, and C.D. Stiles BHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS Science 306 2004 2111 2115 (Pubitemid 40007666)
98. M. Xin, T. Yue, Z. Ma, F.F. Wu, A. Gow, and Q.R. Lu Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice J. Neurosci. 25 2005 1354 1365 (Pubitemid 40250711)
99. M. Wegner, and C.C. Stolt From stem cells to neurons and glia: A Soxist's view of neural development Trends Neurosci. 28 2005 583 588 (Pubitemid 41476688)
100. C.C. Stolt, S. Rehberg, M. Ader, P. Lommes, D. Riethmacher, M. Schachner, U. Bartsch, and M. Wegner Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10 Genes Dev. 16 2002 165 170 (Pubitemid 34075809)
101. H. Li, Y. Lu, H.K. Smith, and W.D. Richardson Olig1 and Sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes J. Neurosci. 27 2007 14375 14382
102. A. Flora, J.J. Garcia, C. Thaller, and H.Y. Zoghbi The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors Proc. Natl. Acad. Sci. USA 104 2007 15382 15387 (Pubitemid 47502926)
103. A.A. Aguirre, R. Chittajallu, S. Belachew, and V. Gallo NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus J. Cell Biol. 165 2004 575 589 (Pubitemid 38679622)
104. S.P. Fancy, S.E. Baranzini, C. Zhao, D.I. Yuk, K.A. Irvine, S. Kaing, N. Sanai, R.J. Franklin, and D.H. Rowitch Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS Genes Dev. 23 2009 1571 1585
105. K.L. Ligon, S. Kesari, M. Kitada, T. Sun, H.A. Arnett, J.A. Alberta, D.J. Anderson, C.D. Stiles, and D.H. Rowitch Development of NG2 neural progenitor cells requires Olig gene function Proc. Natl. Acad. Sci. USA 103 2006 7853 7858
106. S. Copray, V. Balasubramaniyan, J. Levenga, J. de Bruijn, R. Liem, and E. Boddeke Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes Stem cells 24 2006 1001 1010 (Pubitemid 44464733)
107. Q.R. Lu, T. Sun, Z. Zhu, N. Ma, M. Garcia, C.D. Stiles, and D.H. Rowitch Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection Cell 109 2002 75 86 (Pubitemid 34327518)
108. H. Snethen, S. Love, and N. Scolding Disease-responsive neural precursor cells are present in multiple sclerosis lesions Regen Med. 3 2008 835 847
109. M. Imai, M. Watanabe, K. Suyama, T. Osada, D. Sakai, H. Kawada, M. Matsumae, and J. Mochida Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model J. Neurosurg. Spine 8 2008 58 66
110. H.C. Wilson, N.J. Scolding, and C.S. Raine Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions J. Neuroimmunol. 176 2006 162 173 (Pubitemid 44080336)
111. J.G. Hu, Y.X. Wang, J.S. Zhou, C.J. Chen, F.C. Wang, X.W. Li, and H.Z. Lu Differential gene expression in oligodendrocyte progenitor cells, oligodendrocytes and type II astrocytes Tohoku J. Exp. Med. 223 2011 161 176